Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth
- Authors
- 이은주; 안기훈; 홍순철; 이은희; 박용; 김병수
- Issue Date
- 2014
- Publisher
- 대한산부인과학회
- Keywords
- Chemotherapy; Diffuse large B-cell lymphoma; Pregnancy; Preterm birth; R-CHOP
- Citation
- Obstetrics & Gynecology Science, v.57, no.06, pp 526 - 529
- Pages
- 4
- Indexed
- KCI
- Journal Title
- Obstetrics & Gynecology Science
- Volume
- 57
- Number
- 06
- Start Page
- 526
- End Page
- 529
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/9802
- DOI
- 10.5468/ogs.2014.57.6.526
- ISSN
- 2287-8572
2287-8580
- Abstract
- Lymphoma, especially non-Hodgkin’s lymphoma is extremely rare in pregnancy. A 24-year-old pregnant woman was diagnosed with diffuse large B-cell lymphoma (DLBCL), a subgroup of non-Hodgkin’s lymphoma, at 24 weeks’ gestation, and was treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy. After 4 cycles of R-CHOP, she delivered a healthy baby via cesarean section at 34 weeks and 5 days’ gestation because of preterm contraction-related fetal distress. The patient was administered the remaining 2 cycles of R-CHOP after delivery. Follow-up magnetic resonance imaging and computed tomography showed complete remission. Here, we report a rare case of DLBCL successfully treated with R-CHOP chemotherapy during pregnancy, we also performed a systematic review of literature for similar cases. There were 3 earlier reports of R-CHOP treatment for DLBCL. All cases, including our case, resulted in preterm birth. Together, these findings suggest that R-CHOP chemotherapy for DLBCL in pregnancy may be associated with preterm birth.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Obstetrics and Gynecology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.